Covenance is your committed Contract Development and Manufacturing (CDMO) partner for supporting drug development programs. With over 260 scientists engaged in API and Formulations development and a network of 13 manufacturing sites, Covenance is very well positioned to help progress your late stage clinical candidates as well as provide sustainability to your late life cycle products.
We derive our strength in innovation through our research experience of more than 40 years in development of APIs and formulations and process optimization
initiatives
